A recurrent de novo CTBP1 mutation is associated with developmental delay, hypotonia, ataxia, and tooth enamel defects.

Neurogenetics 2016 07 19;17(3):173-8. Epub 2016 Apr 19.

Departments of Pediatrics and Medicine, Columbia University Medical Center, New York, NY, USA.

Exome sequencing is an effective way to identify genetic causes of etiologically heterogeneous conditions such as developmental delay and intellectual disabilities. Using exome sequencing, we have identified four patients with similar phenotypes of developmental delay, intellectual disability, failure to thrive, hypotonia, ataxia, and tooth enamel defects who all have the same de novo R331W missense variant in C-terminal binding protein 1 (CTBP1). CTBP1 is a transcriptional regulator critical for development by coordinating different regulatory pathways. The R331W variant found in these patients is within the C-terminal portion of the PLDLS (Pro-Leu-Asp-Leu-Ser) binding cleft, which is the domain through which CTBP1, interacts with chromatin-modifying enzymes and mediates chromatin-dependent gene repression pathways. This is the first report of mutations within CTBP1 in association with any human disease.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10048-016-0482-4DOI Listing
July 2016
45 Reads
2 Citations
2.884 Impact Factor

Publication Analysis

Top Keywords

developmental delay
12
hypotonia ataxia
8
delay intellectual
8
ataxia tooth
8
tooth enamel
8
exome sequencing
8
enamel defects
8
ctbp1
5
patients c-terminal
4
intellectual disability
4
disability failure
4
failure thrive
4
variant patients
4
thrive hypotonia
4
sequencing identified
4
pro-leu-asp-leu-ser binding
4
disabilities exome
4
pldls pro-leu-asp-leu-ser
4
identified patients
4
phenotypes developmental
4

Similar Publications